Cargando…

CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics

Clustered regularly interspaced short palindromic repeat (CRISPR/Cas) proteins can be designed to bind specified DNA and RNA sequences and hold great promise for the accurate detection of nucleic acids for diagnostics. We integrated commercially available reagents into a CRISPR/Cas9-based lateral fl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osborn, Mark J., Bhardwaj, Akshay, Bingea, Samuel P., Knipping, Friederike, Feser, Colby J., Lees, Christopher J., Collins, Daniel P., Steer, Clifford J., Blazar, Bruce R., Tolar, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918862/ https://www.ncbi.nlm.nih.gov/pubmed/33673107 http://dx.doi.org/10.3390/bioengineering8020023

Ejemplares similares

Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production
por: Feser, Colby J., et al.
Publicado: (2022)

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression
por: Osborn, Mark J., et al.
Publicado: (2018)

Engineering Human Cells Expressing CRISPR/Cas9-Synergistic Activation Mediators for Recombinant Protein Production
por: Feser, Colby J., et al.
Publicado: (2023)

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification
por: Knipping, Friederike, et al.
Publicado: (2017)

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa
por: Webber, Beau R, et al.
Publicado: (2016)

CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells
por: Skvarova Kramarzova, Karolina, et al.
Publicado: (2017)

Differentiation of immortalized human multi-lineage progenitor to alveolar type 2-like cells: angiotensin-converting enzyme 2 expression and binding of severe acute respiratory syndrome coronavirus 2 spike and spike 1 proteins
por: Collins, Daniel P., et al.
Publicado: (2021)

CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells
por: Kluesner, Mitchell G., et al.
Publicado: (2021)

Expression of Telomerase and Telomere Length Are Unaffected by either Age or Limb Regeneration in Danio rerio
por: Lund, Troy C., et al.
Publicado: (2009)

Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa
por: Tolar, Jakub, et al.
Publicado: (2012)

Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa
por: Tolar, Jakub, et al.
Publicado: (2013)

Fluorescence Signal-Readout of CRISPR/Cas Biosensors for Nucleic Acid Detection
por: Huang, Zhaohe, et al.
Publicado: (2022)

Fluorescent tagging of endogenous proteins with CRISPR/Cas9 in primary mouse neural stem cells
por: Morrow, Christopher S., et al.
Publicado: (2021)

CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
por: Shi, Yajun, et al.
Publicado: (2023)

Bone Marrow Stromal and Vascular Smooth Muscle Cells Have Chemosensory Capacity via Bitter Taste Receptor Expression
por: Lund, Troy C., et al.
Publicado: (2013)

Binding of the SARS-CoV-2 Spike Protein to the Asialoglycoprotein Receptor on Human Primary Hepatocytes and Immortalized Hepatocyte-Like Cells by Confocal Analysis
por: Collins, Daniel P, et al.
Publicado: (2021)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Efficient silencing of hepatitis B virus S gene through CRISPR‐mediated base editing
por: Zhou, Hao, et al.
Publicado: (2022)

The MyLO CRISPR-Cas9 toolkit: a markerless yeast localization and overexpression CRISPR-Cas9 toolkit
por: Bean, Björn D M, et al.
Publicado: (2022)

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
por: Yoon, Dok Hyun, et al.
Publicado: (2018)

Detection of a biolistic delivery of fluorescent markers and CRISPR/Cas9 to the pollen tube
por: Nagahara, Shiori, et al.
Publicado: (2021)

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018)

Rapid, Efficient, and Cost-Effective Gene Editing of Enterococcus faecium with CRISPR-Cas12a
por: Chua, Michelle J., et al.
Publicado: (2022)

CRISPR-Cas Controls Cryptic Prophages
por: Song, Sooyeon, et al.
Publicado: (2022)

Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9
por: Barkau, Christopher L., et al.
Publicado: (2019)

CRISPR-Associated Primase-Polymerases are implicated in prokaryotic CRISPR-Cas adaptation
por: Zabrady, Katerina, et al.
Publicado: (2021)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

Improved CRISPR/Cas9 gene editing by fluorescence activated cell sorting of green fluorescence protein tagged protoplasts
por: Petersen, Bent Larsen, et al.
Publicado: (2019)

The Application of CRISPR/Cas Systems for Antiviral Therapy
por: Baddeley, Helen J. E., et al.
Publicado: (2021)

Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize
por: Lee, Keunsub, et al.
Publicado: (2018)

Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection
por: Bhardwaj, Pooja, et al.
Publicado: (2022)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

A CRISPR/Cas9-generated mutation in the zebrafish orthologue of PPP2R3B causes idiopathic scoliosis
por: Seda, Marian, et al.
Publicado: (2023)

The Lrat(−/−) Rat: CRISPR/Cas9 Construction and Phenotyping of a New Animal Model for Retinitis Pigmentosa
por: Koster, Céline, et al.
Publicado: (2021)

Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
por: Papizan, James B., et al.
Publicado: (2021)

Engineered CRISPR-Cas9 nucleases with altered PAM specificities
por: Kleinstiver, Benjamin P., et al.
Publicado: (2015)

Prophages are associated with extensive CRISPR–Cas auto-immunity
por: Nobrega, Franklin L, et al.
Publicado: (2020)

CRISPR/Cas-based customization of pooled CRISPR libraries
por: Kweon, Jiyeon, et al.
Publicado: (2018)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering
por: Sipe, Christopher J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03a9ahtvhcn5jq204t7k61nmvf